Methylprednisolone reduced postextubation laryngeal edema in adults with tracheal intubation

September 2007
ACP Journal Club;Sept/Oct2007, Vol. 147 Issue 2, p48
Academic Journal
The article discusses a clinical study that states that methylprednisolone reduced postextubation laryngeal edema in adults with tracheal intubation. It is stated that in adults with tracheal intubation, 12-hour pretreatment with methylprednisolone was more effective than placebo for preventing postextubation laryngeal edema. Details related to the study and a chart on the same are also provided.


Related Articles

  • Nocebo Effects, Patient-Clinician Communication, and Therapeutic Outcomes. Colloca, Luana; Finniss, Damien // JAMA: Journal of the American Medical Association;2/8/2012, Vol. 307 Issue 6, p567 

    In the article, the authors discuss several topics, namely, the Nocebo effects, patient-clinician communication, and therapeutic outcomes. They define nocebo effects as adverse events that are generated by negative expectations and are the opposite of placebo effects. They claim that both nocebo...

  • Methylprednisolone reduced postextubation laryngeal edema in adults with tracheal intubation: COMMENTARY. Hughes, Christopher M. // ACP Journal Club;Sept/Oct2007, Vol. 147 Issue 2, p48 

    The article offers the author's comments on a clinical study that states that methylprednisolone reduced postextubation laryngeal edema in adults with tracheal intubation. The author states that taken at face value, the study's implications are clear and reasonably strong. He suggests that he...

  • Placebo Therapy and the Law: Prescribe with Care*. Kapp, Marshall B. // American Journal of Law & Medicine;Winter83, Vol. 8 Issue 4, p371 

    The use of placebos by physicians for therapeutic purposes is a common part of clinical medical practice. This Article examines the legal and ethical ramifications of placebo prescription. In particular, ethical concerns are related to substantive legal theories that may be advanced to attack or...

  • No evidence that placebos have powerful clinical effects, study says. Gottlieb, Scott // BMJ: British Medical Journal (International Edition);06/02/2001, Vol. 322 Issue 7298, p1325 

    Reports that treatment with placebo shows no evidence of having powerful clinical effects, according a study conducted at the University of Copenhagen. Reservations by many physicians toward the clinical use of placebos; Details of the study, which tested primarily the clinical effects of...

  • Pregabalin in fibromyalgia - responder analysis from individual patient data. Straube, Sebastian; Derry, Sheena; Moore, R. Andrew; Paine, Jocelyn; McQuay, Henry J. // BMC Musculoskeletal Disorders;2010, Vol. 11, p150 

    Background: Population mean changes are difficult to use in clinical practice. Responder analysis may be better, but needs validating for level of response and treatment duration. A consensus group has defined what constitutes minimal, moderate, and substantial benefit based on pain intensity...

  • Sunitinib. Deeks, Emma D.; Keating, Gillian M. // Drugs;2006, Vol. 66 Issue 17, p2255 

    â–´ Sunitinib arid its active metabolite (SU012662) are selective inhibitors of multiple receptor tyrosine kinases associated with tumour growth and angiogenesis. â–´ The clinical efficacy of oral sunitinib has been demonstrated in patients with advanced gastrointestinal stromal tumours...

  • The lesser of 2 evils: the ethics of placebo-controlled trials. Streiner, David L. // Canadian Journal of Psychiatry;Jul2008, Vol. 53 Issue 7, p430 

    The article discusses the research work of David L. Streiner on the considerations that apply to the ethics of placebo-controlled trials in Ontario. It states that it has been established that placebo-controlled trials present valid evidence on preventive, diagnostic, and therapeutic...

  • Single-Day, Patient-Initiated Famciclovir Therapy for Recurrent Genital Herpes: A Randomized, Double-Blind, Placebo-Controlled Trial. Aoki, Fred Y.; Tyring, Stephen; Diaz-Mitoma, Francisco; Gross, Gerd; Gao, Joseph; Hamed, Kamal // Clinical Infectious Diseases;1/1/2006, Vol. 42 Issue 1, p8 

    Background. Orally administered antiviral therapy for genital herpes improves the time to lesion healing and resolves symptoms during an outbreak. Although traditional therapy for a recurrent episode for healthy adults has consisted of twice-daily dosing for 5 days, recent studies have indicated...

  • Pregabalin: In the Treatment of Postherpetic Neuralgia. Frampton, James E.; Foster, Rachel H. // Drugs;2005, Vol. 65 Issue 1, p111 

    â–´ Pregabalin, the pharmacologically active S-enantiomer of 3-aminomethyl-5-methyl-hexanoic acid, has a similar pharmacological profile to that of its developmental predecessor gabapentin, but showed greater analgesic activity in rodent models of neuropathic pain. â–´ The exact...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics